Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sangamo Therapeutics (SGMOQ) Gains from Sales and Divestitures (2019 - 2021)

Updated

Sangamo Therapeutics' Gains from Sales and Divestitures was $1.03 million in FY2024.

Analysis

Sangamo Therapeutics (SGMOQ) Gains from Sales and Divestitures (2019 - 2021) Analysis & Trends

From FY2009 onward, Sangamo Therapeutics has reported Gains from Sales and Divestitures for 7 years.

  • The FY2024 figure marks the highest annual Gains from Sales and Divestitures in data going back to FY2009.
  • Per Business Quant data, Gains from Sales and Divestitures in earlier years was $52,000 in FY2021 and -$222,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Sangamo Therapeutics 42.03 Mn -72.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 22,000.00
Dec 31, 2020 -25,000.00
Dec 31, 2019 -68,000.00
API Access

Sangamo Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY